| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/11/2002 | US20020042386 Genetic engineering |
| 04/11/2002 | US20020042385 Cloning of a novel 7TM receptor AXOR-2 |
| 04/11/2002 | US20020042384 Integrin-targeting vectors having transfection activity |
| 04/11/2002 | US20020042383 Antiinflammatory agents |
| 04/11/2002 | US20020042381 Antilipemic agents |
| 04/11/2002 | US20020042380 Topical application of ascorbic acid compounds for augmenting the synthesis of epidermal ceramides |
| 04/11/2002 | US20020042379 Sepsis shock |
| 04/11/2002 | US20020042377 Rotamase enzyme activity inhibitors |
| 04/11/2002 | US20020042376 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 04/11/2002 | US20020042361 Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent |
| 04/11/2002 | US20020042360 Antitumor agents |
| 04/11/2002 | US20020042359 Regulators of PPARdelta (beta) and their use in the treatment of obesity and insulin resistance |
| 04/11/2002 | US20020042357 Polypharmacophoric agents |
| 04/11/2002 | US20020042103 Process for the preparation of pseudomonic acid a antibiotic by microbiological method |
| 04/11/2002 | US20020042096 Nucleic acids, proteins, and antibodies |
| 04/11/2002 | US20020042054 Nucleotide sequences for use in the diagnosis and treatment of sleeping disorders |
| 04/11/2002 | US20020042043 Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity |
| 04/11/2002 | US20020041906 Compositions and methods for enhancing therapeutic effects |
| 04/11/2002 | US20020041903 Adjust blood flow to scalp, penis |
| 04/11/2002 | US20020041902 Fluoride as a chemoprotective and chemotheraputic agent for cancer in mammals |
| 04/11/2002 | US20020041898 Novel targeted delivery systems for bioactive agents |
| 04/11/2002 | US20020041897 In biocompatible polymer |
| 04/11/2002 | US20020041894 Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis and pharmaceutical compositions and kit related thereto |
| 04/11/2002 | US20020041889 Enhancing agent for degradation of desmosomes or stratum corneum desquamation |
| 04/11/2002 | US20020041888 Suspension containing microspheres; apoptosis inducing compound |
| 04/11/2002 | US20020041887 Immune response modifier compounds for treatment of TH2 mediated and related diseases |
| 04/11/2002 | US20020041885 Inhibitor of immunoglobulin e antibody production |
| 04/11/2002 | US20020041883 Topical applying |
| 04/11/2002 | US20020041878 Monitoring angiogenesis factor |
| 04/11/2002 | US20020041876 Modulation of angiogenesis |
| 04/11/2002 | US20020041871 Phytase and enzyme |
| 04/11/2002 | US20020041867 Microencapsulated dna for vaccination and gene therapy |
| 04/11/2002 | US20020041862 Medical equipment |
| 04/11/2002 | DE10100586C1 Inhibiting gene expression in cells, useful for e.g. treating tumors, by introducing double-stranded complementary oligoRNA having unpaired terminal bases |
| 04/11/2002 | DE10049937A1 New sugar-modified amidine and guanidine compounds, useful as competitive inhibitors of serine protease, e.g. for treating thrombosis |
| 04/11/2002 | DE10049468A1 New N-alkoxyalkyl-benzimidazole derivatives useful in veterinary medicine for the control of parasitic protozoa |
| 04/11/2002 | DE10049271A1 Production of cyclohexene derivatives with pentadienyl substituents, e.g astaxanthin compounds, comprises reduction of corresponding alken-ynyl derivatives with a mixture of zinc and ammonium or copper salt |
| 04/11/2002 | DE10049225A1 Dermal therapeutic system comprises diclofenac sodium in an acrylate copolymer matrix on a polyester web |
| 04/11/2002 | DE10048714A1 5-Amino-1-penlen-3-ol-Derivate 5-amino-1-penlen-3-ol derivatives |
| 04/11/2002 | DE10047486A1 Phenoxyphenyl Alkansulfonate Phenoxy-phenyl alkane |
| 04/11/2002 | DE10047295A1 Medicinal use of galiella lactone as specific interleukin-6 signal induction inhibitor e.g. in treatment of fibrotic, cerebrovascular or neurodegenerative disease, pain, inflammation or tumors |
| 04/11/2002 | DE10046993A1 Substituierte Zimtsäureguanidide, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltendes Medikament Substituted Zimtsäureguanidide, processes for their preparation, their use as a medicament and they drug-containing |
| 04/11/2002 | CA2641575A1 Stabilization of solid thyroid drug formulations |
| 04/11/2002 | CA2641570A1 Stabilization of solid thyroid drug formulations |
| 04/11/2002 | CA2435976A1 Apoptosis inducers, caspase cascade activators and anticancer agents |
| 04/11/2002 | CA2425712A1 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| 04/11/2002 | CA2425281A1 Diindolylmethane and c-substituted diindolylmethane compositions and methods for the treatment of multiple cancers |
| 04/11/2002 | CA2425266A1 Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension |
| 04/11/2002 | CA2425264A1 Tumor proliferation inhibitors |
| 04/11/2002 | CA2425185A1 Benzimidazole and indole derivatives as crf receptor modulators |
| 04/11/2002 | CA2425124A1 Selective anxiolytic therapeutic agents |
| 04/11/2002 | CA2425097A1 Benzamide compounds as apo b secretion inhibitors |
| 04/11/2002 | CA2425072A1 Wt1 fusion polypeptides and methods for wt1 immunotherapy |
| 04/11/2002 | CA2424993A1 7-carboxy-flavone derivatives, preparation method and therapeutic use |
| 04/11/2002 | CA2424934A1 Association of the cb1 receptor antagonist and sibutramin, for treating obesity |
| 04/11/2002 | CA2424880A1 Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases |
| 04/11/2002 | CA2424870A1 Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells |
| 04/11/2002 | CA2424869A1 Phyllanthus-derived compounds for the prevention and/or treatment of diseases associated with a nucleosidic inhibitor-resistant retrovirus or a non-nucleosidic inhibitor-resistantretrovirus |
| 04/11/2002 | CA2424761A1 Method of treating cancer using dithiocarbamate derivatives |
| 04/11/2002 | CA2424693A1 Induction of blood vessel formation by polynucleotides encoding sphingosine kinases |
| 04/11/2002 | CA2424684A1 Nitroso diphenylamine derivatives |
| 04/11/2002 | CA2424623A1 Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid |
| 04/11/2002 | CA2424622A1 Use of neuropeptide-y antagonists in treatment of alcoholism |
| 04/11/2002 | CA2424621A1 Combination particles for the treatment of asthma |
| 04/11/2002 | CA2424620A1 Inhalation particles incorporating a combination of two or more active ingredients |
| 04/11/2002 | CA2424604A1 Modulation of the transcription of pro-inflammatory gene products |
| 04/11/2002 | CA2424581A1 Compounds useful for treating hypertriglyceridemia |
| 04/11/2002 | CA2424567A1 Method to alter sugar moieties |
| 04/11/2002 | CA2424555A1 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| 04/11/2002 | CA2424303A1 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| 04/11/2002 | CA2424282A1 Diazacycloalkanedione derivatives which are useful as lfa-1 antagonist |
| 04/11/2002 | CA2424279A1 New thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
| 04/11/2002 | CA2424273A1 Citrullimycines, a process for their production and their use as pharmaceuticals |
| 04/11/2002 | CA2424222A1 Inhibitors of prenyl-protein transferase |
| 04/11/2002 | CA2424207A1 Stem cell differentiation-inducing promoter |
| 04/11/2002 | CA2424117A1 Phosphoric acid salt of an integrin receptor antagonist |
| 04/11/2002 | CA2424116A1 Antitumor therapy comprising distamycin derivatives |
| 04/11/2002 | CA2423917A1 Compositions for cleansing skin and treating acne |
| 04/11/2002 | CA2423898A1 Ethers of 7-desmethylrapamycin for use in immunosuppression |
| 04/11/2002 | CA2423888A1 Hydroxyesters of 7-desmethylrapamycin |
| 04/11/2002 | CA2423883A1 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
| 04/11/2002 | CA2423860A1 Substituted 1-aminobutan-3-ol derivatives |
| 04/11/2002 | CA2423656A1 Methods and compositions for enhancing angiogenesis |
| 04/11/2002 | CA2423558A1 Delivery system for multi-pharmaceutical active materials at various release rates |
| 04/11/2002 | CA2423436A1 Methods and compositions for modulating t cell activation and uses thereof |
| 04/11/2002 | CA2423431A1 Devices and methods for management of inflammation |
| 04/11/2002 | CA2423312A1 Condensed pyridoindole derivatives |
| 04/11/2002 | CA2422810A1 New oxabispidine compound useful in the treatment of cardiac arrhythmias |
| 04/11/2002 | CA2421782A1 Quinoline and quinolinone derivatives as metabotropic glutamate receptor antagonists |
| 04/11/2002 | CA2421776A1 New process for the production of oxabispidines |
| 04/11/2002 | CA2421417A1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases |
| 04/11/2002 | CA2419777A1 Pharmaceutical compounds |
| 04/10/2002 | EP1195378A1 Pyridotriazines and pyridopyridazines |
| 04/10/2002 | EP1195377A1 Diesters of maleic or fumaric acid |
| 04/10/2002 | EP1195178A1 Immunotrophic preparation for treating adenotonsillary hypertrophy |
| 04/10/2002 | EP1195166A2 Use of a vasopressin antagonist such as conivaptan in the manufacture of a medicament for treating pulmonary hypertension |
| 04/10/2002 | EP1195165A1 Fibrosis inhibitors containing as the active ingredient sphingosine-1-phosphate receptor agonist or sphingosine-1-phosphate |
| 04/10/2002 | EP1195162A1 Vaccine preparations containing fatty acids as constituent |
| 04/10/2002 | EP1195160A1 Sustained release trimetazidine pharmaceutical compositions and a method of their preparation |
| 04/10/2002 | EP1195159A1 Therapeutic combination of ascorbate with lysine or arginine for prevention and treatment of cancer |